Two Houston companies have combined their businesses. Photo by Sergio Trevino

A Houston-based cannabis company has formalized its ongoing relationship with one of the city’s most popular breweries. Bayou City Hemp Company announced that it has purchased 8th Wonder Brewery, Distillery, and Cannabis.

The acquisition deepens a relationship that dates back to 2021, when 8th Wonder and Bayou City Hemp partnered to create Wonder Water, a non-alcoholic beverage available with either CBD or Delta-8 that became the top-selling to-go product at 8th Wonder.

Going forward, the combined company aims to capture a healthy share of the Texas market for adult beverages by offering a full lineup of beer, spirits, and cannabis-infused drinks.

“Our commitment to provide quality products and trusted brands to consumers is strengthened with 8th Wonder, who has been a Texas staple in craft beer and spirits for over a decade,” Bayou City CEO Benjamin Meggs said in a statement. “We look forward to growing market share and distribution to the entire portfolio of products through expanded resources and combined expertise. This is not merely an acquisition; it is a bold declaration of our intent to lead and innovate in the heart of Texas.”

The combined company aims to utilize 8th Wonder’s existing distribution channels to get its products on to as many store shelves as possible, including stores such as H-E-B, Walmart, Kroger, Total Wine, and Spec’s. A capital infusion from Bayou City Hemp will focus on marketing and promotion, helping the company to increase excitement for and awareness of the brand.

“Significant capital will be infused to build out the necessary infrastructure,” Meggs said in response to CultureMap’s request for comment about the combined company’s plans. “This infrastructure will enhance our operational capabilities positioning Bayou City to enter new emerging beverage categories such as Cannabis, NA Beer, and RTD Spirits [ready-to-drink] among others.”

While all those changes will mostly happen behind the scenes, customers will notice upgrades to the current 8th Wonder brewery, taproom, distillery, and beer garden to match the brand’s new look.

Founded in 2011, 8th Wonder Brewery evolved out of the Eatsie Boys food truck. Branded with a nostalgic affection for Houston, it developed a following for beers such as Dome Faux’m (cream ale), Rocket Fuel (Vietnamese coffee porter), and Haterade (gose). Over time, it expanded into spirits with a distillery and cannabis with a dispensary.

Bayou City Hemp Company opened in 2019. It produces edibles, vapes, additives, and seltzers that aim to meet the growing consumer demand for cannabis-based products.

Going forward, Meggs will remain in his role as CEO where he’ll be joined by Bayou City Hemp’s existing chief business officer, Jeromy Sherman, CFO Karen Trotter, chief revenue officer Joel Canada, and chief innovation officer Stephen Horton. 8th Wonder co-founder Ryan Soroka will serve as chief brand and marketing officer, while 8th Wonder co-founder and brewmaster Aaron Corsi will become COO.

“From day one at 8th Wonder, our goal was to build a hundred-year company,” Soroka added. “This transaction will provide the leadership and resources needed to achieve that dream. We look forward to a refreshed and revitalized 8th Wonder as we move forward with Bayou City Hemp into the exciting future of the beverage and cannabis industries.”

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Intel Corp. and Rice University sign research access agreement

innovation access

Rice University’s Office of Technology Transfer has signed a subscription agreement with California-based Intel Corp., giving the global company access to Rice’s research portfolio and the opportunity to license select patented innovations.

“By partnering with Intel, we are creating opportunities for our research to make a tangible impact in the technology sector,” Patricia Stepp, assistant vice president for technology transfer, said in a news release.

Intel will pay Rice an annual subscription fee to secure the option to evaluate specified Rice-patented technologies, according to the agreement. If Intel chooses to exercise its option rights, it can obtain a license for each selected technology at a fee.

Rice has been a hub for innovation and technology with initiatives like the Rice Biotech Launch Pad, an accelerator focused on expediting the translation of the university’s health and medical technology; RBL LLC, a biotech venture studio in the Texas Medical Center’s Helix Park dedicated to commercializing lifesaving medical technologies from the Launch Pad; and Rice Nexus, an AI-focused "innovation factory" at the Ion.

The university has also inked partnerships with other tech giants in recent months. Rice's OpenStax, a provider of affordable instructional technologies and one of the world’s largest publishers of open educational resources, partnered with Microsoft this summer. Google Public Sector has also teamed up with Rice to launch the Rice AI Venture Accelerator, or RAVA.

“This agreement exemplifies Rice University’s dedication to fostering innovation and accelerating the commercialization of groundbreaking research,” Stepp added in the news release.

Houston team develops low-cost device to treat infants with life-threatening birth defect

infant innovation

A team of engineers and pediatric surgeons led by Rice University’s Rice360 Institute for Global Health Technologies has developed a cost-effective treatment for infants born with gastroschisis, a congenital condition in which intestines and other organs are developed outside of the body.

The condition can be life-threatening in economically disadvantaged regions without access to equipment.

The Rice-developed device, known as SimpleSilo, is “simple, low-cost and locally manufacturable,” according to the university. It consists of a saline bag, oxygen tubing and a commercially available heat sealer, while mimicking the function of commercial silo bags, which are used in high-income countries to protect exposed organs and gently return them into the abdominal cavity gradually.

Generally, a single-use bag can cost between $200 and $300. The alternatives that exist lack structure and require surgical sewing. This is where the SimpleSilo comes in.

“We focused on keeping the design as simple and functional as possible, while still being affordable,” Vanshika Jhonsa said in a news release. “Our hope is that health care providers around the world can adapt the SimpleSilo to their local supplies and specific needs.”

The study was published in the Journal of Pediatric Surgery, and Jhonsa, its first author, also won the 2023 American Pediatric Surgical Association Innovation Award for the project. She is a recent Rice alumna and is currently a medical student at UTHealth Houston.

Bindi Naik-Mathuria, a pediatric surgeon at UTMB Health, served as the corresponding author of the study. Rice undergraduates Shreya Jindal and Shriya Shah, along with Mary Seifu Tirfie, a current Rice360 Global Health Fellow, also worked on the project.

In laboratory tests, the device demonstrated a fluid leakage rate of just 0.02 milliliters per hour, which is comparable to commercial silo bags, and it withstood repeated disinfection while maintaining its structure. In a simulated in vitro test using cow intestines and a mock abdominal wall, SimpleSilo achieved a 50 percent reduction of the intestines into the simulated cavity over three days, also matching the performance of commercial silo bags. The team plans to conduct a formal clinical trial in East Africa.

“Gastroschisis has one of the biggest survival gaps from high-resource settings to low-resource settings, but it doesn’t have to be this way,” Meaghan Bond, lecturer and senior design engineer at Rice360, added in the news release. “We believe the SimpleSilo can help close the survival gap by making treatment accessible and affordable, even in resource-limited settings.”